Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004883 · ClinicalTrials.gov registry record · NA
Solutions for Hunger and Regulating Eating
A NA study of Overweight and Obesity, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05004883: Active NA study of Overweight and Obesity, sponsored by University of California, San Diego.
NCT05004883 is a NA study of Overweight and Obesity that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 300 participants, above the 226-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05004883, a NA study of Overweight and Obesity, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this proposed study is to collect efficacy data on ROC+ compared to an active comparator (AC) and to Behavioral Weight Loss (BWL) for participants who are high in Food Responsiveness.
Primary Outcome
Body Mass Index as measured by height and weight
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Weight Loss
- BEHAVIORAL Regulation of Cues Enhanced
- BEHAVIORAL Nutrition Education, Stress Management and Social Support
Study Locations (1)
California
- UCSD Center for Healthy Eating and Activity Research (CHEAR) - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-08-15 |
| Phase | NA |
What the registry record for NCT05004883 still lists
NCT05004883 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 226-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (33% higher).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Behavioral Weight Loss is the first listed.
NCT05004883 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05004883 about?
NCT05004883 is a clinical study titled "Solutions for Hunger and Regulating Eating". The objective of this proposed study is to collect efficacy data on ROC+ compared to an active comparator (AC) and to Behavioral Weight Loss (BWL) for participants who are high in Food Responsiveness.
What is the current status of trial NCT05004883?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-09-01. Estimated completion is 2026-08-15.
What conditions does trial NCT05004883 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT05004883?
The interventions under investigation include: Behavioral Weight Loss (BEHAVIORAL), Regulation of Cues Enhanced (BEHAVIORAL), Nutrition Education, Stress Management and Social Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05004883?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05004883 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05004883's enrollment target sits among peer trials
300 25th of 115 higher than 90 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI